SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-04-004383
Filing Date
2004-03-30
Accepted
2004-03-30 15:28:23
Documents
6
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f97689e10vk.htm 10-K 687898
3 EXHIBIT 21.1 f97689exv21w1.txt EX-21.1 184
4 EXHIBIT 23.1 f97689exv23w1.txt EX-23.1 1039
5 EXHIBIT 31.1 f97689exv31w1.txt EX-31.1 3768
6 EXHIBIT 31.2 f97689exv31w2.txt EX-31.2 3932
7 EXHIBIT 32.1 f97689exv32w1.txt EX-32.1 2270
  Complete submission text file 0000950134-04-004383.txt   701157
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22570 | Film No.: 04700658
SIC: 2833 Medicinal Chemicals & Botanical Products